Front Psychiatry. 2020 May 20;11:380. doi: 10.3389/fpsyt.2020.00380. eCollection 2020.
Depression in the Elderly. Consensus Statement of the Spanish Psychogeriatric Association.
Frontiers in psychiatry
Luis Agüera-Ortiz, María Dolores Claver-Martín, María Dolores Franco-Fernández, Jorge López-Álvarez, Manuel Martín-Carrasco, María Isabel Ramos-García, Manuel Sánchez-Pérez
Affiliations
Affiliations
- Servicio de Psiquiatría, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
- Madrid Salud, Ayuntamiento de Madrid, Madrid, Spain.
- Psychiatry Department, University of Sevilla, Seville, Spain.
- FIDMAG Research Foundation (CIBERSAM), Barcelona, Spain.
- Instituto de Psiquiatría y Salud Mental, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
- Unidad de Psiquiatría Geriátrica, Hospital Sagrat Cor. Martorell, Barcelona, Spain.
PMID: 32508684
PMCID: PMC7251154 DOI: 10.3389/fpsyt.2020.00380
Abstract
INTRODUCTION: Present knowledge about depression in the elderly is still scarce and often controversial, despite its high frequency and impact. This article reports the results and most relevant conclusions of a Delphi-based consensus on geriatric depression promoted by the Spanish Psychogeriatric Association.
METHODS: A 78-item questionnaire was developed by 7 highly specialized geriatric psychiatrists and was evaluated using the Modified Delphi technique in two rounds answered by 35 psychiatrists with an extensive expertise in geriatric depression. The topics and number of questions (in brackets) covered were: concepts, clinical aspects, and risk factors (12); screening and diagnosis (7); psychotic depression (17); depression and dementia (5); antidepressant drug treatment (18); non-pharmacological biological treatments (5); psychotherapeutic treatments (4); comorbidity and preventive aspects (6); professional training needed (4). In addition, the expert panel's opinion on the antidepressants of choice in 21 common comorbid conditions and on different strategies to approach treatment-resistant cases in terms of both efficacy and safety was assessed.
RESULTS: After the two rounds of the Delphi process, consensus was reached for 59 (75.6%) of the 78 items. Detailed recommendations are included in the text. Considering pharmacological treatments, agomelatine was the most widely mentioned drug to be recommended in terms of safety in comorbid conditions. Desvenlafaxine, sertraline, and vortioxetine, were the most frequently recommended antidepressants in comorbid conditions in general. Combining parameters of efficacy and safety, experts recommended the following steps to address cases of treatment resistance: 1. Escalation to the maximum tolerated dose; 2. Change of antidepressant; 3. Combination with another antidepressant; 4. Potentiation with an antipsychotic or with lamotrigine; 5. Potentiation with lithium; 6. Potentiation with dopamine agonists or methylphenidate.
DISCUSSION AND CONCLUSIONS: Consensus was reached for a high number of items as well as for the management of depression in the context of comorbid conditions and in resistant cases. In the current absence of sufficient evidence-based information, our results can be used to inform medical doctors about clinical recommendations that might reduce uncertainty in the diagnosis and treatment of elderly patients with depressive disorders.
Copyright © 2020 Agüera-Ortiz, Claver-Martín, Franco-Fernández, López-Álvarez, Martín-Carrasco, Ramos-García and Sánchez-Pérez.
Keywords: antidepressant drugs; clinical recommendations; comorbidity; consensus statement; depression; elderly; treatment-resistance
References
- Actas Esp Psiquiatr. 2011 Jan-Feb;39(1):20-31 - PubMed
- Am J Geriatr Psychiatry. 2012 Jan;20(1):5-17 - PubMed
- J ECT. 2013 Jun;29(2):106-8 - PubMed
- Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):195-207 - PubMed
- JAMA. 2017 May 23;317(20):2114-2122 - PubMed
- Int Psychogeriatr. 2017 Nov;29(11):1801-1824 - PubMed
- J Affect Disord. 2014 Oct;168:276-83 - PubMed
- J Health Serv Res Policy. 2006 Oct;11(4):218-24 - PubMed
- Int J Geriatr Psychiatry. 2003 Aug;18(8):694-9 - PubMed
- Int J Geriatr Psychiatry. 2016 Apr;31(4):412-20 - PubMed
- Psychol Med. 2019 Jan;49(2):232-242 - PubMed
- BMC Med. 2016 Nov 3;14(1):161 - PubMed
- Clin Geriatr Med. 2014 Aug;30(3):517-34 - PubMed
- Am J Psychiatry. 2000 Mar;157(3):351-9 - PubMed
- J Clin Psychiatry. 2011 Jan;72(1):e04 - PubMed
- JAMA. 1997 Oct 8;278(14):1186-90 - PubMed
- Lancet. 2015 Aug 22;386(9995):743-800 - PubMed
- Int Psychogeriatr. 2017 May;29(5):717-726 - PubMed
- Convuls Ther. 1993;9(1):39-42 - PubMed
- J Affect Disord. 2010 Jun;123(1-3):222-9 - PubMed
- Int J Geriatr Psychiatry. 2006 Dec;21(12):1139-49 - PubMed
- Oncologist. 2009 Jan;14(1):60-6 - PubMed
- Arch Gen Psychiatry. 2010 Mar;67(3):277-85 - PubMed
- Int J Geriatr Psychiatry. 2008 Sep;23(9):915-21 - PubMed
- JAMA. 2001 Mar 14;285(10):1299-307 - PubMed
- Med J Aust. 2005 Jun 20;182(12):627-32 - PubMed
- Aten Primaria. 2020 Apr;52(4):224-232 - PubMed
- J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):140-4 - PubMed
- JAMA Psychiatry. 2017 Jul 1;74(7):673-674 - PubMed
- Am J Geriatr Psychiatry. 2017 Oct;25(10):1135-1149 - PubMed
- Am J Psychiatry. 2005 Apr;162(4):711-7 - PubMed
- Am J Geriatr Psychiatry. 2010 May;18(5):442-51 - PubMed
- Am J Geriatr Psychiatry. 2018 Jan;26(1):107-122 - PubMed
- J Affect Disord. 2009 Oct;117 Suppl 1:S15-25 - PubMed
- Fam Pract. 2006 Jun;23(3):369-77 - PubMed
- J Affect Disord. 2015 Jul 1;179:6-13 - PubMed
- Neuropsychiatr Dis Treat. 2016 Aug 24;12:2105-14 - PubMed
- J Psychiatr Res. 2016 Jun;77:42-51 - PubMed
- J Psychiatr Res. 2016 Nov;82:1-7 - PubMed
- Alzheimers Dement. 2017 Jan;13(1):59-71 - PubMed
- Maturitas. 2014 Oct;79(2):147-52 - PubMed
- Am J Psychiatry. 1999 Dec;156(12):1865-70 - PubMed
- Am J Psychiatry. 2011 Jul;168(7):681-8 - PubMed
- Int J Geriatr Psychiatry. 2007 Feb;22(2):101-5 - PubMed
- Crisis. 2016 Mar;37(2):161-5 - PubMed
- Med Clin North Am. 2017 Jul;101(4):807-821 - PubMed
- Am J Psychiatry. 1998 Feb;155(2):178-83 - PubMed
- J Gerontol Nurs. 2018 Mar 1;44(3):31-38 - PubMed
- J Clin Psychiatry. 2019 Mar 19;80(2): - PubMed
- Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004853 - PubMed
- Arq Neuropsiquiatr. 2012 Aug;70(8):617-20 - PubMed
- Int J Geriatr Psychiatry. 2015 Mar;30(3):265-73 - PubMed
- J Neurol. 2019 Aug 14;: - PubMed
- J Affect Disord. 2013 Sep 5;150(2):161-70 - PubMed
- Int J Geriatr Psychiatry. 2003 Aug;18(8):686-93 - PubMed
- Am J Psychiatry. 2006 Sep;163(9):1493-501 - PubMed
- Curr Neuropharmacol. 2015;13(5):577-91 - PubMed
- Metabolism. 2005 May;54(5 Suppl 1):39-44 - PubMed
- Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45 - PubMed
- JAMA. 2012 Sep 5;308(9):909-18 - PubMed
- J Affect Disord. 2017 Oct 15;221:123-131 - PubMed
- Maturitas. 2014 Oct;79(2):184-90 - PubMed
- Am J Geriatr Psychiatry. 2008 Jun;16(6):498-505 - PubMed
- J Clin Psychiatry. 2018 Jul 31;79(5): - PubMed
- Br J Psychiatry. 2015 Jan;206(1):67-71 - PubMed
- PLoS One. 2011;6(6):e20476 - PubMed
- Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79 - PubMed
- Convuls Ther. 1986;2(1):7-17 - PubMed
- Int J Geriatr Psychiatry. 2014 Aug;29(8):789-96 - PubMed
- Indian J Psychiatry. 2018 Feb;60(Suppl 3):S341-S362 - PubMed
- Can J Psychiatry. 2016 Sep;61(9):588-603 - PubMed
- Am J Geriatr Psychiatry. 2013 Oct;21(10):973-86 - PubMed
- Clin Ther. 2009 May;31(5):945-61 - PubMed
- Br Med J (Clin Res Ed). 1986 May 24;292(6532):1365-7 - PubMed
- Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:27-33 - PubMed
- Am J Geriatr Psychiatry. 2015 Mar;23(3):261-73 - PubMed
- Psychother Psychosom. 2010;79(5):285-94 - PubMed
- J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):914-23 - PubMed
- Am J Geriatr Psychiatry. 2019 Oct;27(10):1138-1152 - PubMed
- J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):465-71 - PubMed
- J Affect Disord. 1991 Jul;22(3):135-48 - PubMed
- Handb Clin Neurol. 2019;167:429-435 - PubMed
- Psychiatr Clin North Am. 2013 Dec;36(4):483-96 - PubMed
- Curr Psychiatry Rep. 2016 Apr;18(4):40 - PubMed
- J Am Geriatr Soc. 2015 May;63(5):1002-9 - PubMed
- J Affect Disord. 2008 Jul;109(1-2):193-7 - PubMed
- Curr Psychiatry Rep. 2014 Aug;16(8):456 - PubMed
- N Engl J Med. 2014 Sep 25;371(13):1228-36 - PubMed
- Neurology. 2009 Mar 10;72(10):886-92 - PubMed
- Mol Psychiatry. 2018 Aug 31;: - PubMed
- Psychol Med. 2019 Feb;49(3):353-365 - PubMed
- Am J Geriatr Psychiatry. 2016 Oct;24(10):913-7 - PubMed
- Rev Psiquiatr Salud Ment. 2018 Oct - Dec;11(4):216-226 - PubMed
- Crisis. 2011;32(2):88-98 - PubMed
- Br J Psychiatry. 2010 Mar;196(3):226-34 - PubMed
- Arch Gen Psychiatry. 2011 Jan;68(1):33-41 - PubMed
- J Alzheimers Dis. 2010;20(1):175-83 - PubMed
- Int J Geriatr Psychiatry. 2016 May;31(5):526-35 - PubMed
Publication Types